Myeloproliferative Disorders and CLL Flashcards
What translocation drives CML?
Philadelphia chromosome +ve, (9;22)
What does the BCR-ABL gene cause?
Increased tyrosine kinase activity- which is why treatment is imatinib (BCR-ABL tyrosine kinase inhibitor)
What is CML?
A myeloproliferative disorder.
Neoplastic proliferation of myeloid cells, especially granulocytes and their precursors; basophils are characteristically increased.
Age group typically affected by CML?
MIDDLE AGED 40-60
Common feature of CML?
SPLENOMEGALY
When is imatinib treatment for CML most effective?
Chronic phase
Blood results for CML?
Neutrophilia
Raised WCC
Blood film of CML?
LEFT SHIFT- high number of young immature white blood cells
Leukocytosis
Eosiniophilia
Basophilia
Hypoblated megakaryocytes in bone marrow
Diagnosis of CML?
Use FISH currently, PCR for BCR-ABL1 fusion gene resulting form t(9;22), forming philadelphia chromosome.
Phases of CML and features?
Chronic- responsive to therapy <5% blasts
Accelerated- >10% blasts, less responsive to therapy, increasing manifestations such as splenomegaly
Blast phase: >20% blasts behaves like Acute leukaemia, treatment similar to AML possibly with allogeneic SCT for young people.
Bone marrow of CML?
HYPERCELLULAR BM with spectrum of immature (myelocytes) and mature granulocytic cells in the blood.
Blood film of CLL?
SMEAR CELLS/SMUDGE CELLS
Remember SMEAR CLLs
High WBC with lymphocytosis
Difference between CLL and small lymphocytic leukaemia (SLL)?
Essentially the SAME disease process but CLL primarily seen in the bone marrow
SLL in the LYMPH NODES (generalised lymphadenopathy)
Age range affected by CLL and gender more commonly affected?
Elderly >50
Twice as common in MALES
What is CLL associated with?
Autoimmune haemolytic anaemia and ITP